 protein binding salicylates Kawasaki disease patients Kawasaki disease low serum concentrations salicylates high doses free unbound drug responsible pharmacologic effects salicylates salicylate protein binding patients Kawasaki disease acute phase disease binding salicylate children Kawasaki disease subacute phase Mean serum albumin concentration gm/L acute phase gm/L subsequent subacute phase Salicylate binding serum albumin total salicylate levels acute phase Kawasaki disease children average twofold increase free salicylate normoalbuminemic control subjects nomogram free salicylate levels total salicylate serum albumin concentrations